Cargando…

The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study

Prostate cancer (PCa) has almost the highest genetic transmission that mimics an autosomal dominance hereditary pattern of cancers in some families. Its incidence in Arab countries was reported to be steadily increasing. Aim. To determine the relevance of HLA-DPA1 rs3077 (A/G) SNP with prostate canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Alenzi, Mohammed Jayed, Ghazy, Amany A., Taha, Diaa-Eldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084672/
https://www.ncbi.nlm.nih.gov/pubmed/33976942
http://dx.doi.org/10.1155/2021/5539851
_version_ 1783686202373701632
author Alenzi, Mohammed Jayed
Ghazy, Amany A.
Taha, Diaa-Eldin
author_facet Alenzi, Mohammed Jayed
Ghazy, Amany A.
Taha, Diaa-Eldin
author_sort Alenzi, Mohammed Jayed
collection PubMed
description Prostate cancer (PCa) has almost the highest genetic transmission that mimics an autosomal dominance hereditary pattern of cancers in some families. Its incidence in Arab countries was reported to be steadily increasing. Aim. To determine the relevance of HLA-DPA1 rs3077 (A/G) SNP with prostate cancer's risk and/or severity. Subjects and Methods. Forty PCa patients and forty age matched patients with benign prostatic hyperplasia (BPH), as a control group, were enrolled in the study. Serum levels of urea, creatinine, total prostate-specific antigen (PSA), and free PSA were measured. PSA ratio was determined as well. Genotyping of HLA-DPA1 rs3077 (A/G) SNP was done using real-time PCR. Results. The measured lab parameters, except free PSA, were significantly higher among PCa patients in comparison to controls (P < 0.001(∗)). Moreover, PSA ratio was significantly high among PCa patients (P < 0.001(∗)). HLA-DPA1 rs3077 GG genotype was more frequent in PCa patients and the associated OR was 2.546 (P=0.059), while AA genotype was more frequent in the control group and the associated OR was 0.145 (P=0.081). Frequency of G allele was higher among PCa patients than the control group while A allele frequency was significantly decreased (P=0.034(∗)) (protective allele). On multivariate analysis, there is no significant correlation found between HLA-DPA1 rs3077 SNP and PSA ratio (OR = 4.5, 95% CI = 1.2–17.4, P=0.856). Conclusion. HLA-DPA1 rs3077 G allele could be a risk factor for prostate cancer. However, HLA-DPA1 rs3077 SNP has no relation to PCa severity.
format Online
Article
Text
id pubmed-8084672
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80846722021-05-10 The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study Alenzi, Mohammed Jayed Ghazy, Amany A. Taha, Diaa-Eldin Prostate Cancer Research Article Prostate cancer (PCa) has almost the highest genetic transmission that mimics an autosomal dominance hereditary pattern of cancers in some families. Its incidence in Arab countries was reported to be steadily increasing. Aim. To determine the relevance of HLA-DPA1 rs3077 (A/G) SNP with prostate cancer's risk and/or severity. Subjects and Methods. Forty PCa patients and forty age matched patients with benign prostatic hyperplasia (BPH), as a control group, were enrolled in the study. Serum levels of urea, creatinine, total prostate-specific antigen (PSA), and free PSA were measured. PSA ratio was determined as well. Genotyping of HLA-DPA1 rs3077 (A/G) SNP was done using real-time PCR. Results. The measured lab parameters, except free PSA, were significantly higher among PCa patients in comparison to controls (P < 0.001(∗)). Moreover, PSA ratio was significantly high among PCa patients (P < 0.001(∗)). HLA-DPA1 rs3077 GG genotype was more frequent in PCa patients and the associated OR was 2.546 (P=0.059), while AA genotype was more frequent in the control group and the associated OR was 0.145 (P=0.081). Frequency of G allele was higher among PCa patients than the control group while A allele frequency was significantly decreased (P=0.034(∗)) (protective allele). On multivariate analysis, there is no significant correlation found between HLA-DPA1 rs3077 SNP and PSA ratio (OR = 4.5, 95% CI = 1.2–17.4, P=0.856). Conclusion. HLA-DPA1 rs3077 G allele could be a risk factor for prostate cancer. However, HLA-DPA1 rs3077 SNP has no relation to PCa severity. Hindawi 2021-04-21 /pmc/articles/PMC8084672/ /pubmed/33976942 http://dx.doi.org/10.1155/2021/5539851 Text en Copyright © 2021 Mohammed Jayed Alenzi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Alenzi, Mohammed Jayed
Ghazy, Amany A.
Taha, Diaa-Eldin
The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title_full The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title_fullStr The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title_full_unstemmed The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title_short The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study
title_sort weight of hla-dpa1 rs3077 single nucleotide polymorphism in prostate cancer, a multicenter study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084672/
https://www.ncbi.nlm.nih.gov/pubmed/33976942
http://dx.doi.org/10.1155/2021/5539851
work_keys_str_mv AT alenzimohammedjayed theweightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy
AT ghazyamanya theweightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy
AT tahadiaaeldin theweightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy
AT alenzimohammedjayed weightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy
AT ghazyamanya weightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy
AT tahadiaaeldin weightofhladpa1rs3077singlenucleotidepolymorphisminprostatecanceramulticenterstudy